Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Definitive HealthcareDH -5.09%49 Cash Ratio is 1.27 as of Mar. 2026, which is 30% below its 10-year median of 1.82. GuruFocus rates DH with a GF Score™ of 49/100 and a GF Value™ of $4.43 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Definitive Healthcare ranks better than 69.58% on this metric.
Definitive Healthcare has a Cash Ratio of 1.27. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Definitive Healthcare's Cash Ratio or its related term are showing as below:
DH'
s Cash Ratio Range Over the Past 10 Years
Min: 0.12 Med: 1.82 Max: 3.15
Current: 1.27
During the past 7 years, Definitive Healthcare's highest Cash Ratio was 3.15. The lowest was 0.12. And the median was 1.82.
DH's Cash Ratio is ranked better than 69.58% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 0.59
vs DH: 1.27
Definitive Healthcare (NAS:DH) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Definitive Healthcare's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Definitive Healthcare Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Definitive Healthcare's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Definitive Healthcare (DH) has a Cash Ratio of 1.27 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Definitive Healthcare and its competitors. This is 30% below median its historical median of 1.82. Over the past decade, Definitive Healthcare's Cash Ratio has ranged from 0.12 to 3.15. According to the industry distribution chart, Definitive Healthcare ranks #202 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 30.4%.
Is Definitive Healthcare's Cash Ratio too high?
Definitive Healthcare's current Cash Ratio of 1.27 is 30% below median its 10-year median of 1.82. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 3.15. The Healthcare Providers & Services industry median Cash Ratio is 0.59. Definitive Healthcare's value of 1.27 is 115.3% above this industry median. Based on the distribution chart, Definitive Healthcare ranks #202 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Definitive Healthcare has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Definitive Healthcare's Cash Ratio compare to DRIO and CCLD?
According to the Healthcare Providers & Services industry distribution chart, Definitive Healthcare ranks #202 out of 664 companies for Cash Ratio. This puts Definitive Healthcare in the upper half of its industry. The industry median Cash Ratio is 0.59. Definitive Healthcare's value of 1.27 is 115.3% above this benchmark. Historically, Definitive Healthcare's own Cash Ratio has ranged from 0.12 to 3.15 over the past decade. While the company's 10-year median is 1.82 vs. the industry median of 0.59, Definitive Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.59, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Definitive Healthcare's current Cash Ratio of 1.27 is 115.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Definitive Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Definitive Healthcare's current Cash Ratio is 1.27, which is 30% below median its own 10-year median of 1.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Definitive Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Definitive Healthcare (DH) is currently considered Possible Value Trap. The stock's GF Value™ is $4.43, compared to a current price of $0.74 — trading 83.3% below its estimated fair value. The current Cash Ratio is 1.27, which is 30% below median its 10-year median of 1.82 and 115.3% above the Healthcare Providers & Services industry median of 0.59. Definitive Healthcare's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Definitive Healthcare (DH), the current Cash Ratio is 1.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Definitive Healthcare (DH) Overvalued in 2026?
Based on GuruFocus' analysis, Definitive Healthcare stock appears to be undervalued.
The current stock price of $0.74 is trading 83.3% below its estimated GF Value™ of $4.43.
GuruFocus considers Definitive Healthcare to be Possible Value Trap.
Key valuation signals for DH:
Cash Ratio: 1.27 (30% below median its 10-year median of 1.82)
GF Value™: $4.43 vs. price of $0.74 (83.3% below fair value)
Industry Position: 115.3% above the Healthcare Providers & Services median (#202 of 664)
No single metric tells the full story. See the DH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
49GF Score
Get the complete analysis for DH
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DH has been successfully added to your 
